UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 255

Sortiert nach

Prostate Cancer Diffusion‐Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion‐Weighting Level Matter?

Journal of magnetic resonance imaging, 2022-03, Vol.55 (3), p.842-853

2022

Link zum Volltext

Verfügbarkeit prüfen

Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial

European urology, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Population-based Organised Prostate Cancer Testing: Results from the First Invitation of 50-year-old Men

European urology, 2024-03, Vol.85 (3), p.207-214

2024

Link zum Volltext

Verfügbarkeit prüfen

Prostate Specific Antigen and Biopsy Contamination in the Göteborg-1 Randomized, Population-Based, Prostate Cancer Screening Trial

The Journal of urology, 2022-11, Vol.208 (5), p.1018-1027

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality

Journal of medical screening, 2012-09, Vol.19 (3), p.133-140

2012

Link zum Volltext

Verfügbarkeit prüfen

Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol 2016;70:767–8

European urology, 2016-11, Vol.70 (5), p.769-770

2016

Link zum Volltext

Verfügbarkeit prüfen

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

The Lancet (British edition), 2014-12, Vol.384 (9959), p.2027-2035

2014

Link zum Volltext

Verfügbarkeit prüfen

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

Annals of internal medicine, 2017-10, Vol.167 (7), p.449

2017

Link zum Volltext

Verfügbarkeit prüfen

Health Economic Analysis of Open and Robot-assisted Laparoscopic Surgery for Prostate Cancer Within the Prospective Multicentre LAPPRO Trial

European urology, 2018-12, Vol.74 (6), p.816-824

2018

Link zum Volltext

Verfügbarkeit prüfen

Association of surgeon and hospital volume with short-term outcomes after robotassisted radical prostatectomy : Nationwide, population-based study

PloS one, 2021-06, Vol.16 (6 June 2021)

2021

Link zum Volltext

Verfügbarkeit prüfen

Erectile Function and Oncologic Outcomes Following Open Retropubic and Robot-assisted Radical Prostatectomy: Results from the LAParoscopic Prostatectomy Robot Open Trial

European urology, 2018-04, Vol.73 (4), p.618-627

2018

Link zum Volltext

Verfügbarkeit prüfen

Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial

European urology, 2023-02, Vol.83 (2), p.103-109

2023

Link zum Volltext

Verfügbarkeit prüfen

Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.04.024

European urology, 2016

2016

Link zum Volltext

Verfügbarkeit prüfen

Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume centres

Scandinavian journal of urology, 2019-10, Vol.53 (5), p.304-311

2019

Link zum Volltext

Verfügbarkeit prüfen

The drama of prostate cancer diagnostics

The lancet oncology, 2017-03, Vol.18 (3), p.e132-e132

2017

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial” [Eur Urol (2022)]

European urology, 2023-03, Vol.83 (3), p.e88-e88

2023

Link zum Volltext

Verfügbarkeit prüfen

Reply from Authors re: H. Ballentine Carter. Prostate-specific Antigen–Based Screening for Prostate Cancer: The Irony of It All. Eur Urol 2013;65:710–11

European urology, 2013-11, Vol.64 (5), p.711-712

2013

Link zum Volltext

Verfügbarkeit prüfen

Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial

BJU international, 2021-03, Vol.127 (3), p.361-368

2021

Link zum Volltext

Verfügbarkeit prüfen

1731 HOW SCREENING DOES AFFECT ERECTILE FUNCTION AND URINARY CONTINENCE FOLLOWING RADICAL PROSTATECTOMY - RESULTS FROM THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC)

The Journal of urology, 2010, Vol.183 (4), p.e669-e669

2010

Link zum Volltext

Verfügbarkeit prüfen

The quality of radical prostatectomies must be ensured

Läkartidningen, 2017-07, Vol.114

2017

Link zum Volltext

Verfügbarkeit prüfen

Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer

BJU international, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

The value of a bladder-filling protocol for patients with prostate cancer who receive post-operative radiation: results from a prospective clinical trial

Acta oncologica, 2019-04, Vol.58 (4), p.463-468

2019

Link zum Volltext

Verfügbarkeit prüfen

Results from 22 years of Follow-Up in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial

The Journal of urology, 2022, Vol.208 (2), p.292

2022

Link zum Volltext

Verfügbarkeit prüfen

The impact of design and performance in PSA screening: differences between ERSPC centers

European urology, 2019-04, Vol.76 (3), p.276-279

2019

Link zum Volltext

Verfügbarkeit prüfen

26 – 50 von 255

Suche als RSS-Feed

Aktive Filter

ThemaProstate-Specific Antigen - Blood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(233)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Prostate Cancer Diffusion‐Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion‐Weighting Level Matter?

Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial

Population-based Organised Prostate Cancer Testing: Results from the First Invitation of 50-year-old Men

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

Prostate Specific Antigen and Biopsy Contamination in the Göteborg-1 Randomized, Population-Based, Prostate Cancer Screening Trial

Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality

Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol 2016;70:767–8

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

Health Economic Analysis of Open and Robot-assisted Laparoscopic Surgery for Prostate Cancer Within the Prospective Multicentre LAPPRO Trial

Association of surgeon and hospital volume with short-term outcomes after robotassisted radical prostatectomy : Nationwide, population-based study

Erectile Function and Oncologic Outcomes Following Open Retropubic and Robot-assisted Radical Prostatectomy: Results from the LAParoscopic Prostatectomy Robot Open Trial

Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial

Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.04.024

Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume centres

The drama of prostate cancer diagnostics

Corrigendum to “Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial” [Eur Urol (2022)]

Reply from Authors re: H. Ballentine Carter. Prostate-specific Antigen–Based Screening for Prostate Cancer: The Irony of It All. Eur Urol 2013;65:710–11

Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial

1731 HOW SCREENING DOES AFFECT ERECTILE FUNCTION AND URINARY CONTINENCE FOLLOWING RADICAL PROSTATECTOMY - RESULTS FROM THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC)

The quality of radical prostatectomies must be ensured

Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer

The value of a bladder-filling protocol for patients with prostate cancer who receive post-operative radiation: results from a prospective clinical trial

Results from 22 years of Follow-Up in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial

The impact of design and performance in PSA screening: differences between ERSPC centers

Aktive Filter

Suchergebnisse filtern